These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2643864)

  • 21. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
    Overlack A; Stumpe KO
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prazosin and beta-blocker monotherapy on serum lipids: a cross-over, placebo-controlled study.
    Magarian EO; Dietz AJ; Freeman DS; Carlson JD
    J Clin Pharmacol; 1987 Oct; 27(10):756-61. PubMed ID: 2892862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forearm and finger hemodynamics, blood pressure control, and lipid changes in diabetic hypertensive patients treated with atenolol and prazosin. A brief report.
    Kwan CM; Shepherd AM; Johnson J; Taylor WF; Brockway BA
    Am J Med; 1989 Jan; 86(1B):55-8. PubMed ID: 2913773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.
    Velasco M; Silva H; Feldstein E; Pellicer R; Morillo J; Urbina-Quintana A; Hernández-Pieretti O
    Eur J Clin Pharmacol; 1985; 28(5):513-6. PubMed ID: 3899672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial antihypertensive drug therapy. Final report of a randomized, controlled trial comparing alpha-blocker and diuretic.
    Stamler R; Stamler J; Gosch FC; Berkson DM; Dyer AR; Hershinow P
    Hypertension; 1988 Dec; 12(6):574-81. PubMed ID: 3060429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.
    Superko HR; Wood PD; Krauss RM
    Am J Med; 1989 Jan; 86(1B):26-31. PubMed ID: 2913769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Labetalol in the treatment of hypertension in elderly and younger patients.
    Abernethy DR; Bartos P; Plachetka JR
    J Clin Pharmacol; 1987 Nov; 27(11):902-6. PubMed ID: 2892866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
    Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
    Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
    Misson R; Merkel T; Cutler RE
    Am J Cardiol; 1984 Jan; 53(3):51A-54A. PubMed ID: 6364760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prazosin in hypertension with and without methyldopa.
    Kochar MS; Zeller JR; Itskovitz HD
    Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
    Hurt E; Velasco M; Silva H; Camejo G
    Biomed Biochim Acta; 1987; 46(1):111-8. PubMed ID: 3107546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term antihypertensive effects of prazosin and atenolol.
    Itskovitz HD; Krug K; Khoury S; Mollura JL
    Am J Med; 1989 Jan; 86(1B):82-6. PubMed ID: 2913776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of labetalol in moderate to severe hypertension.
    Macdonald I; Hua AS; Thomas GW; Woo KT; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1980 Apr; 1(7):325-7. PubMed ID: 7393061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of labetalol in elderly patients with essential hypertension.
    Giles TD; Weber M; Bartels DW; Gregory MC; Burris JF; Due D; Sirgo MA
    J Clin Pharmacol; 1991 Jun; 31(6):556-60. PubMed ID: 1880221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter comparison of dilevalol to placebo in patients with mild hypertension.
    Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.
    Lowenstein J; Neusy AJ
    Am J Med; 1984 Feb; 76(2A):79-84. PubMed ID: 6702864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.